Lucira Health Inc. (NASDAQ:LHDX)’s traded shares stood at 0.37 million during the last session. At the close of trading, the stock’s price was $6.13, to imply a decrease of -7.12% or -$0.47 in intraday trading. The LHDX share’s 52-week high remains $37.99, putting it -519.74% down since that peak but still an impressive 31.0% since price per share fell to its 52-week low of $4.23. The company has a valuation of $261.69M, with an average of 0.21 million shares in intraday trading volume over the past 10 days and average of 712.20K shares over the past 3 months.
Analysts have given a consensus recommendation of a Hold for Lucira Health Inc. (LHDX), translating to a mean rating of 3.30. Of 3 analyst(s) looking at the stock, 0 analyst(s) give LHDX a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 0 recommend it as a Buy. 1 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.51.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
After registering a -7.12% downside in the last session, Lucira Health Inc. (LHDX) has traded red over the past five days. The stock hit a weekly high of 6.87 this Friday, 10/08/21, dropping -7.12% in its intraday price action. The 5-day price performance for the stock is -11.03%, and -28.22% over 30 days. With these gigs, the year-to-date price performance is -75.46%. Short interest in Lucira Health Inc. (NASDAQ:LHDX) saw shorts transact 1.1 million shares and set a 1.09 days time to cover.
Analysts on Wall Street suggest a consensus price target of $8.50, implying an increase of 27.88% to the stock’s current value. The extremes give us $8.00 and $9.00 for target low and target high price respectively. As such, LHDX has been trading -46.82% off suggested target high and -30.51% from its likely low.
Lucira Health Inc. (LHDX) estimates and forecasts
Looking at statistics comparing Lucira Health Inc. share performance against respective industry, we note that the company has outperformed competitors. Lucira Health Inc. (LHDX) shares are -43.81% down over the last 6 months, with its year-to-date growth rate higher than industry average at 87.74% against 17.40%.
Revenue forecast for the current quarter as set by 3 analysts is $18.3 million. Meanwhile, for the quarter ending Dec 2021, a total of 3 analyst(s) estimate revenue growth to $28.4 million.
Lucira Health Inc. has its next earnings report out in November. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Lucira Health Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Lucira Health Inc. (NASDAQ:LHDX)’s Major holders
Lucira Health Inc. insiders hold 2.44% of total outstanding shares, with institutional holders owning 50.06% of the shares at 51.31% float percentage. In total, 50.06% institutions holds shares in the company, led by EPIQ Capital Group, LLC. As of Mar 30, 2021, the company held over 13.23 million shares (or 34.31% of shares), all amounting to roughly $160.13 million.
The next major institution holding the largest number of shares is Capital Research Global Investors with 1.12 million shares, or about 2.89% of shares outstanding. As of the market price on Mar 30, 2021, these shares were worth $13.5 million.
We also have Smallcap World Fund and American Funds Insurance Ser-Global Small Capitalization Fund as the top two Mutual Funds with the largest holdings of the Lucira Health Inc. (LHDX) shares. Going by data provided on Mar 30, 2021, Smallcap World Fund holds roughly 0.89 million shares. This is just over 2.31% of the total shares, with a market valuation of $10.8 million. Data from the same date shows that the other fund manager holds a little less at 0.22 million, or 0.58% of the shares, all valued at about 2.7 million.